Intrinsic value of LifePoint Health - LPNT

Previous Close

$47.90

  Intrinsic Value

$53.86

stock screener

  Rating & Target

hold

+12%

Previous close

$47.90

 
Intrinsic value

$53.86

 
Up/down potential

+12%

 
Rating

hold

We calculate the intrinsic value of LPNT stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.9

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  6,417
  6,564
  6,733
  6,923
  7,132
  7,363
  7,613
  7,885
  8,177
  8,491
  8,827
  9,185
  9,566
  9,972
  10,402
  10,858
  11,340
  11,851
  12,390
  12,959
  13,560
  14,193
  14,861
  15,565
  16,306
  17,086
  17,907
  18,771
  19,680
  20,636
Variable operating expenses, $m
  2,852
  2,913
  2,983
  3,062
  3,150
  3,245
  3,350
  3,463
  3,584
  3,715
  3,673
  3,822
  3,981
  4,150
  4,329
  4,519
  4,719
  4,932
  5,156
  5,393
  5,643
  5,907
  6,185
  6,477
  6,786
  7,110
  7,452
  7,812
  8,190
  8,588
Fixed operating expenses, $m
  3,326
  3,399
  3,474
  3,550
  3,628
  3,708
  3,789
  3,873
  3,958
  4,045
  4,134
  4,225
  4,318
  4,413
  4,510
  4,609
  4,711
  4,814
  4,920
  5,028
  5,139
  5,252
  5,368
  5,486
  5,606
  5,730
  5,856
  5,985
  6,116
  6,251
Total operating expenses, $m
  6,178
  6,312
  6,457
  6,612
  6,778
  6,953
  7,139
  7,336
  7,542
  7,760
  7,807
  8,047
  8,299
  8,563
  8,839
  9,128
  9,430
  9,746
  10,076
  10,421
  10,782
  11,159
  11,553
  11,963
  12,392
  12,840
  13,308
  13,797
  14,306
  14,839
Operating income, $m
  239
  252
  276
  310
  355
  409
  474
  549
  635
  731
  1,019
  1,138
  1,267
  1,409
  1,563
  1,730
  1,910
  2,105
  2,313
  2,538
  2,778
  3,034
  3,309
  3,601
  3,913
  4,245
  4,599
  4,974
  5,374
  5,797
EBITDA, $m
  922
  946
  983
  1,032
  1,093
  1,166
  1,250
  1,346
  1,455
  1,575
  1,709
  1,855
  2,014
  2,188
  2,375
  2,578
  2,796
  3,030
  3,281
  3,550
  3,837
  4,143
  4,469
  4,817
  5,187
  5,580
  5,997
  6,440
  6,911
  7,409
Interest expense (income), $m
  139
  157
  161
  166
  172
  178
  186
  194
  202
  212
  222
  233
  244
  257
  270
  284
  299
  315
  332
  349
  368
  388
  409
  431
  454
  478
  504
  531
  559
  589
  621
Earnings before tax, $m
  83
  92
  110
  138
  176
  224
  281
  347
  423
  509
  787
  893
  1,010
  1,139
  1,279
  1,431
  1,595
  1,773
  1,964
  2,170
  2,390
  2,626
  2,878
  3,148
  3,435
  3,742
  4,068
  4,415
  4,784
  5,176
Tax expense, $m
  22
  25
  30
  37
  48
  60
  76
  94
  114
  137
  212
  241
  273
  307
  345
  386
  431
  479
  530
  586
  645
  709
  777
  850
  927
  1,010
  1,098
  1,192
  1,292
  1,398
Net income, $m
  60
  67
  80
  101
  129
  163
  205
  253
  309
  372
  574
  652
  738
  831
  934
  1,045
  1,165
  1,294
  1,434
  1,584
  1,745
  1,917
  2,101
  2,298
  2,508
  2,731
  2,970
  3,223
  3,492
  3,779

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,410
  6,558
  6,726
  6,916
  7,125
  7,355
  7,606
  7,877
  8,169
  8,483
  8,818
  9,176
  9,557
  9,962
  10,392
  10,847
  11,329
  11,839
  12,377
  12,946
  13,546
  14,179
  14,846
  15,549
  16,289
  17,069
  17,889
  18,752
  19,660
  20,616
Adjusted assets (=assets-cash), $m
  6,410
  6,558
  6,726
  6,916
  7,125
  7,355
  7,606
  7,877
  8,169
  8,483
  8,818
  9,176
  9,557
  9,962
  10,392
  10,847
  11,329
  11,839
  12,377
  12,946
  13,546
  14,179
  14,846
  15,549
  16,289
  17,069
  17,889
  18,752
  19,660
  20,616
Revenue / Adjusted assets
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
Average production assets, $m
  5,012
  5,127
  5,259
  5,406
  5,570
  5,750
  5,946
  6,158
  6,386
  6,632
  6,894
  7,174
  7,471
  7,788
  8,124
  8,480
  8,857
  9,255
  9,676
  10,121
  10,590
  11,085
  11,606
  12,156
  12,735
  13,344
  13,985
  14,660
  15,370
  16,117
Working capital, $m
  -58
  -59
  -61
  -62
  -64
  -66
  -69
  -71
  -74
  -76
  -79
  -83
  -86
  -90
  -94
  -98
  -102
  -107
  -112
  -117
  -122
  -128
  -134
  -140
  -147
  -154
  -161
  -169
  -177
  -186
Total debt, $m
  2,978
  3,073
  3,181
  3,303
  3,438
  3,586
  3,747
  3,921
  4,109
  4,311
  4,526
  4,756
  5,001
  5,262
  5,538
  5,831
  6,141
  6,469
  6,815
  7,181
  7,567
  7,973
  8,402
  8,854
  9,330
  9,831
  10,359
  10,914
  11,498
  12,112
Total liabilities, $m
  4,122
  4,217
  4,325
  4,447
  4,582
  4,729
  4,891
  5,065
  5,253
  5,454
  5,670
  5,900
  6,145
  6,405
  6,682
  6,975
  7,285
  7,612
  7,959
  8,324
  8,710
  9,117
  9,546
  9,998
  10,474
  10,975
  11,503
  12,058
  12,642
  13,256
Total equity, $m
  2,289
  2,341
  2,401
  2,469
  2,544
  2,626
  2,715
  2,812
  2,916
  3,028
  3,148
  3,276
  3,412
  3,556
  3,710
  3,872
  4,044
  4,226
  4,419
  4,622
  4,836
  5,062
  5,300
  5,551
  5,815
  6,094
  6,386
  6,695
  7,019
  7,360
Total liabilities and equity, $m
  6,411
  6,558
  6,726
  6,916
  7,126
  7,355
  7,606
  7,877
  8,169
  8,482
  8,818
  9,176
  9,557
  9,961
  10,392
  10,847
  11,329
  11,838
  12,378
  12,946
  13,546
  14,179
  14,846
  15,549
  16,289
  17,069
  17,889
  18,753
  19,661
  20,616
Debt-to-equity ratio
  1.300
  1.310
  1.320
  1.340
  1.350
  1.370
  1.380
  1.390
  1.410
  1.420
  1.440
  1.450
  1.470
  1.480
  1.490
  1.510
  1.520
  1.530
  1.540
  1.550
  1.560
  1.580
  1.590
  1.600
  1.600
  1.610
  1.620
  1.630
  1.640
  1.650
Adjusted equity ratio
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  60
  67
  80
  101
  129
  163
  205
  253
  309
  372
  574
  652
  738
  831
  934
  1,045
  1,165
  1,294
  1,434
  1,584
  1,745
  1,917
  2,101
  2,298
  2,508
  2,731
  2,970
  3,223
  3,492
  3,779
Depreciation, amort., depletion, $m
  683
  694
  707
  722
  738
  756
  776
  797
  820
  845
  689
  717
  747
  779
  812
  848
  886
  926
  968
  1,012
  1,059
  1,108
  1,161
  1,216
  1,273
  1,334
  1,399
  1,466
  1,537
  1,612
Funds from operations, $m
  743
  761
  788
  823
  867
  920
  981
  1,050
  1,129
  1,216
  1,264
  1,369
  1,485
  1,610
  1,746
  1,893
  2,050
  2,220
  2,401
  2,596
  2,804
  3,025
  3,262
  3,513
  3,781
  4,066
  4,368
  4,689
  5,029
  5,390
Change in working capital, $m
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -7
  -8
  -8
  -9
Cash from operations, $m
  744
  762
  789
  825
  869
  922
  983
  1,053
  1,131
  1,219
  1,267
  1,373
  1,488
  1,614
  1,750
  1,897
  2,055
  2,224
  2,406
  2,601
  2,809
  3,031
  3,268
  3,520
  3,788
  4,073
  4,375
  4,697
  5,038
  5,399
Maintenance CAPEX, $m
  -491
  -501
  -513
  -526
  -541
  -557
  -575
  -595
  -616
  -639
  -663
  -689
  -717
  -747
  -779
  -812
  -848
  -886
  -926
  -968
  -1,012
  -1,059
  -1,108
  -1,161
  -1,216
  -1,273
  -1,334
  -1,399
  -1,466
  -1,537
New CAPEX, $m
  -97
  -115
  -132
  -148
  -164
  -180
  -196
  -212
  -228
  -245
  -262
  -280
  -298
  -317
  -336
  -356
  -377
  -399
  -421
  -445
  -469
  -495
  -521
  -549
  -579
  -609
  -641
  -675
  -710
  -747
Cash from investing activities, $m
  -588
  -616
  -645
  -674
  -705
  -737
  -771
  -807
  -844
  -884
  -925
  -969
  -1,015
  -1,064
  -1,115
  -1,168
  -1,225
  -1,285
  -1,347
  -1,413
  -1,481
  -1,554
  -1,629
  -1,710
  -1,795
  -1,882
  -1,975
  -2,074
  -2,176
  -2,284
Free cash flow, $m
  156
  146
  145
  151
  164
  185
  212
  246
  287
  335
  341
  403
  473
  550
  635
  728
  830
  940
  1,060
  1,189
  1,328
  1,477
  1,638
  1,810
  1,993
  2,190
  2,400
  2,623
  2,862
  3,115
Issuance/(repayment) of debt, $m
  78
  95
  108
  122
  135
  148
  161
  174
  188
  202
  216
  230
  245
  260
  276
  293
  310
  328
  346
  366
  386
  407
  429
  452
  476
  501
  527
  555
  584
  614
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  78
  95
  108
  122
  135
  148
  161
  174
  188
  202
  216
  230
  245
  260
  276
  293
  310
  328
  346
  366
  386
  407
  429
  452
  476
  501
  527
  555
  584
  614
Total cash flow (excl. dividends), $m
  234
  241
  253
  273
  299
  333
  373
  421
  475
  537
  557
  634
  718
  810
  911
  1,021
  1,140
  1,268
  1,406
  1,554
  1,714
  1,884
  2,067
  2,261
  2,469
  2,691
  2,927
  3,178
  3,446
  3,729
Retained Cash Flow (-), $m
  -46
  -53
  -60
  -68
  -75
  -82
  -89
  -97
  -104
  -112
  -120
  -128
  -136
  -145
  -153
  -163
  -172
  -182
  -192
  -203
  -214
  -226
  -238
  -251
  -264
  -278
  -293
  -308
  -324
  -341
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  25
  26
  26
  27
  28
  29
  29
  30
  32
  33
  34
  35
  37
  38
  40
  42
  43
  45
  47
  50
  52
  54
  57
  59
  62
  65
  68
  72
  75
  79
Cash available for distribution, $m
  189
  188
  193
  205
  224
  251
  284
  324
  371
  425
  437
  506
  582
  666
  758
  858
  968
  1,086
  1,214
  1,351
  1,499
  1,658
  1,828
  2,011
  2,205
  2,413
  2,634
  2,870
  3,121
  3,388
Discount rate, %
  8.50
  8.93
  9.37
  9.84
  10.33
  10.85
  11.39
  11.96
  12.56
  13.19
  13.85
  14.54
  15.26
  16.03
  16.83
  17.67
  18.55
  19.48
  20.46
  21.48
  22.55
  23.68
  24.86
  26.11
  27.41
  28.78
  30.22
  31.73
  33.32
  34.99
PV of cash for distribution, $m
  174
  158
  147
  141
  137
  135
  133
  131
  128
  123
  105
  99
  92
  83
  74
  64
  54
  44
  35
  28
  21
  15
  11
  8
  5
  3
  2
  1
  1
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.

FINANCIAL RATIOS  of  LifePoint Health (LPNT)

Valuation Ratios
P/E Ratio 15.7
Price to Sales 0.3
Price to Book 0.9
Price to Tangible Book
Price to Cash Flow 4.4
Price to Free Cash Flow 54.7
Growth Rates
Sales Growth Rate 22.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 45.5%
Cap. Spend. - 3 Yr. Gr. Rate 16.7%
Financial Strength
Quick Ratio 4
Current Ratio 0.1
LT Debt to Equity 132.7%
Total Debt to Equity 133.7%
Interest Coverage 2
Management Effectiveness
Return On Assets 3.4%
Ret/ On Assets - 3 Yr. Avg. 3.8%
Return On Total Capital 2.4%
Ret/ On T. Cap. - 3 Yr. Avg. 3.1%
Return On Equity 5.5%
Return On Equity - 3 Yr. Avg. 6.5%
Asset Turnover 1
Profitability Ratios
Gross Margin 35.4%
Gross Margin - 3 Yr. Avg. 36.2%
EBITDA Margin 11%
EBITDA Margin - 3 Yr. Avg. 12.4%
Operating Margin 3.2%
Oper. Margin - 3 Yr. Avg. 4.5%
Pre-Tax Margin 3.2%
Pre-Tax Margin - 3 Yr. Avg. 4.5%
Net Profit Margin 1.9%
Net Profit Margin - 3 Yr. Avg. 2.7%
Effective Tax Rate 35.6%
Eff/ Tax Rate - 3 Yr. Avg. 35.1%
Payout Ratio 0%

LPNT stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the LPNT stock intrinsic value calculation we used $6291 million for the last fiscal year's total revenue generated by LifePoint Health. The default revenue input number comes from 2017 income statement of LifePoint Health. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our LPNT stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.5%, whose default value for LPNT is calculated based on our internal credit rating of LifePoint Health, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of LifePoint Health.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of LPNT stock the variable cost ratio is equal to 44.5%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $3254 million in the base year in the intrinsic value calculation for LPNT stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for LifePoint Health.

Corporate tax rate of 27% is the nominal tax rate for LifePoint Health. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the LPNT stock is equal to 0.4%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for LPNT are equal to 78.1%.

Life of production assets of 10 years is the average useful life of capital assets used in LifePoint Health operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for LPNT is equal to -0.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2243 million for LifePoint Health - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 40 million for LifePoint Health is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of LifePoint Health at the current share price and the inputted number of shares is $1.9 billion.

RELATED COMPANIES Price Int.Val. Rating
UHS Universal Heal 112.67 108.18  hold
THC Tenet Healthca 35.11 17.17  sell
SSY Sunlink Health 1.40 0.56  str.sell
HCA HCA Healthcare 108.00 28.12  str.sell

COMPANY NEWS

▶ LifePoint Surges 40% on Report of Acquisition Talks   [Jul-20-18 06:11PM  TheStreet.com]
▶ LifePoint-owned hospital settles whistleblower lawsuit   [Jun-22-18 08:28AM  American City Business Journals]
▶ LifePoint: 1Q Earnings Snapshot   [07:16AM  Associated Press]
▶ Castleview Hospital Named Duke LifePoint Quality Affiliate   [Apr-03-18 11:57AM  Business Wire]
▶ LifePoint Health, Inc. to Host Earnings Call   [Feb-23-18 08:00AM  ACCESSWIRE]
▶ LifePoint reports 4Q loss   [07:19AM  Associated Press]
▶ LifePoint Health Facilities Recognized by March of Dimes   [Jan-09-18 11:48AM  Business Wire]
▶ LifePoint misses Street 3Q forecasts   [07:15AM  Associated Press]
▶ LifePoint Health Completes Sale of Rockdale Medical Center   [Oct-02-17 04:30PM  Business Wire]
▶ Should You Buy LifePoint Health Inc (LPNT) Now?   [Sep-22-17 05:26PM  Simply Wall St.]
▶ LifePoint beats 2Q profit forecasts   [Aug-01-17 09:32PM  Associated Press]
▶ Hospitals Take Another Hit From Latest Senate Health Plan   [Jul-13-17 01:25PM  TheStreet.com]
▶ Nashville health care CEO named co-chairman of chamber's Partnership 2020   [Jul-11-17 12:30PM  American City Business Journals]
▶ Senate's Delay in Medicaid Pullback Boosts Hospitals   [Jun-22-17 12:01PM  TheStreet.com]
▶ LifePoint beats 1Q profit forecasts   [07:10AM  Associated Press]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.